Loading…

Characterization of the Phenotypic and Genotypic Antibiotic Resistance Markers in Escherichia coli ( E. coli ) Associated With Diabetes and Nondiabetic Patients

Individuals with diabetes are more susceptible to urinary tract infections (UTIs) than those without the disease. This study aimed to determine the phenotypic and genotypic antibiotic resistance profiles of in diabetic and nondiabetic patients. A total of 374 clean-catch midstream urine specimens we...

Full description

Saved in:
Bibliographic Details
Published in:International journal of microbiology 2025-01, Vol.2025 (1), p.3694023
Main Authors: Adjei, David Nana, Mughogho, Thomas Stuart, Michael, Olu-Taiwo, Saidu, Sarah, Amegatcher, Gloria, Forson, Akua Obeng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Individuals with diabetes are more susceptible to urinary tract infections (UTIs) than those without the disease. This study aimed to determine the phenotypic and genotypic antibiotic resistance profiles of in diabetic and nondiabetic patients. A total of 374 clean-catch midstream urine specimens were screened for uropathogens, and antibiogram analysis was done on isolates by the Kirby-Bauer disc diffusion method, followed by phenotypic confirmation of extended spectrum beta-lactamase (ESBL) production. In addition, polymerase chain reaction (PCR) assays were carried out to determine ESBL genotypes. Overall, we observed UTIs prevalence of 19.8% and 10.7% in diabetic and nondiabetic patients. Females exhibited higher UTI prevalence than males in both groups ([71.8% and 28.2%] vs. [85% and 15%]) (   0.05). We observed CTX-M as the most common ESBL genotype, in combination with other ESBL genes present in some isolates. Nitrofurantoin and ceftriaxone antibiotics were efficacious. Appropriate prescription of antibiotic therapy, and the prevention of transmission of resistant genes in the context of public health can be facilitated by routine monitoring of the resistance profiles and ESBL markers in patients with and without diabetes.
ISSN:1687-918X
1687-9198
DOI:10.1155/ijm/3694023